LIMINATUS PHARM EPS - Earnings per Share 1971-1970 | LIMN

LIMINATUS PHARM eps - earnings per share from 1971 to 1970. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
LIMINATUS PHARM Annual EPS
LIMINATUS PHARM Quarterly EPS
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $0.000B
Liminatus Pharma LLC operates as a clinical-stage immuno-oncology company which develops novel cancer therapies. Liminatus Pharma LLC is based in LA Palma, California.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.886B 0.00
Oaktree Acquisition III Life Sciences (OACC) United States $0.235B 0.00
Aduro Clean Technologies (ADUR) Canada $0.157B 0.00
Range Capital Acquisition (RANG) United States $0.144B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.099B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.092B 0.00
YHN Acquisition I (YHNA) $0.082B 0.00
Youxin Technology (YAAS) China $0.040B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.035B 0.00
Sky Quarry (SKYQ) United States $0.015B 0.00
PicoCELA (PCLA) Japan $0.011B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.010B 0.00
SMART DGTL GRP (SDM) $0.000B 0.00
WINCHESTER BCP (WSBK) $0.000B 0.00
YUANBAO INC (YB) China $0.000B 0.00
CANTOR EQ PT II (CEPT) $0.000B 0.00